MEDICARE Part DBIOSIMILARSADALIMUMABThis study examines formulary coverage of brand-name adalimumab and biosimilars across Medicare Part D plans.Klebanoff, Matthew J.Li, PengxiangLin, John K.Doshi, Jalpa A.JAMA: Journal of the American Medical Association...
Examples of FDA-approved biosimilars include:Nivestym (filgrastim-aafi), a biosimilar to Neupogen Ixifi (infliximab-qbtx), a biosimilar to Remicade Eticovo (etanercept-ykro), a biosimilar to Enbrel Amjevita (adalimumab-atto), a biosimilar to Humira Mvasi (bevacizumab-awwb), a biosimilar to ...